Edinburgh-based health tech startup Hearing Diagnostics has secured £1.1m as it eyes commercialisation in the US.
Founded in 2017, Hearing Diagnostics has developed technology designed to improve the quality of hearing tests.
The company is looking to expand the deployment of its services through increased partnerships with retail locations and high-street optical chains.
In the US, recent regulatory changes in over-the-counter audio testing have created an opportunity for the Scottish firm to bring its tech to a new market.
“Hearing loss usually advances slowly and unnoticeably and has severe consequences if left unmanaged. Our mission is to make reliable hearing testing accessible outside of specialist clinics to drive the early diagnosis of hearing loss and to ensure positive patient outcomes,” said Hearing Diagnostics co-founder.
“There is a global market potential for our accurate Audimetroid hearing screening technology, and with the latest investment round led by Archangels, we can start unlocking that potential.”
The investment was led by Archangels, a syndicate of angel investors. Other participants in the round included Scottish Enterprise, which backed the company through its Scottish co-investment fund.
“Hearing Diagnostics’ market approach with manufacturers and retailers can transform diagnostic pathways,” said Niki McKenzie, joint managing director at Archangels.
“This is technology is based on deep scientific research, early feedback from the market has been very positive and we are excited to see how the wider market as commercialisation builds.”
The new funding will allow the company to expand its team, which currently consists of five employees.